Subtyping of Clinical Strains of Mycobacterium leprae Using Single Nucleotide Polymorphism (SNPs) Markers in Leprosy Patients in Côte d'Ivoire

Amon Aby Christiane^1, , Coulibaly Kpanhonri Eve Christelle², Dehe Bahou Roger¹, Yavo Konan Albert¹, Kouakou Luc Venance³, Coulibaly Gninwélé Anne-Edwige^{1, 2}, Kakou N’Gazoa Solange¹, Tian-Bi Yves-Nathan² and Coulibaly N'Golo David¹

¹Molecular Biology Platform, Pasteur Institute of Côte d’Ivoire, BP 490 Abidjan, Abidjan Côte d’Ivoire

²UFR Biosciences, Laboratory of Biology and Health, Félix Houphouet Boigny-university, Abidjan Côte d’Ivoire

³Department of epidemiological viruses, Pasteur Institute of Côte d’Ivoire, BP 490 Abidjan, Abidjan Côte d’Ivoire

Cite this paper:
Amon Aby Christiane, Coulibaly Kpanhonri Eve Christelle, Dehe Bahou Roger, Yavo Konan Albert, Kouakou Luc Venance, Coulibaly Gninwélé Anne-Edwige, Kakou N’Gazoa Solange, Tian-Bi Yves-Nathan and Coulibaly N'Golo David. Subtyping of Clinical Strains of Mycobacterium leprae Using Single Nucleotide Polymorphism (SNPs) Markers in Leprosy Patients in Côte d'Ivoire. American Journal of Microbiological Research. 2025; 13(2):33-37. doi: 10.12691/ajmr-13-2-3

Abstract

Leprosy is a disease caused mainly by Mycobacterium leprae. The mode of transmission has yet to be elucidated. In order to understand its etiology, Mycobacterium leprae was genotyped into 4 types and 16 subtypes using molecular biology techniques. The overall aim of this study was to identify the subtypes of genotype 4 identified in clinical strains of M. leprae in leprosy patients in Côte d'Ivoire, using Single Nucleotide Polymorphisms (SNP) genetic markers. The biological material used consisted of dermal juices and nasal mucus collected from 40 patients clinically diagnosed with leprosy at the Institut Raoul Follereau of Côte d'Ivoire (IRFCI). Conventional PCR amplification revealed a high rate of positive M. leprae detection, i.e. 77.5% (62 /80). 5% (4 /80) of the strains identified had all three types of mutation (insertion, deletion and HPT). However, only one strain identified subtype O, characterized by the insertion of a T base at position Ins: 978589 and by the presence of a T base at position Del: 1476519. Subtype O of the identified M. leprae genotype 4 is thought to circulate in Côte d'Ivoire.

Keywords:
Mycobacterium leprae PCR SNP marker Subtype O Côte d’Ivoire

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Avanzi, C, Busso, P, Benjak, A, Transmission of drug-resistant leprosy in Guinea- Conakry detected using molecular epidemiological approaches, Clinical Infectious Diseases, 63 (11). 1482-1484. 2016.
[2]	Cole, S, T, and Singh, P, History and phylogeography of leprosy, In Leprosy and Buruli Ulcer Springer, 3-12. 2022.
[3]	WHO, Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives. Weekly Epidemiological Record, 95, 417-438. 2019.
[4]	Aubry P, and Gaüzère B, Neglected tropical diseases, Medecine Tropicale. 56, 344-356. 2021.
[5]	WHO, Global leprosy update, 2016: Accelerating reduction of disease burden. Weekly Epidemiological Record, 92, 501-520. 2017.
[6]	Sigg, N, Marion, E, Gnimavo, R., Johnson, R. , Martin, L. and Habib, A, Interest of quantitative PCR for leprosy diagnosis. A study in rural Benin, Annals of Dermatology and Venereology. 146, 276-277. 2019.
[7]	Ahuja, M, and Pathak, V, K, Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases, Journal of Global Antimicrobial Resistance, 30, 282-285. 2022.
[8]	WHO, Global strategy for leprosy control 2016-2020 Cataloguing at source WHO/SEARO Library, 32. 2022.
[9]	WHO, towards zero leprosy, Global strategy for leprosy control (Hansen's disease) 2021-2030, 30. 2023.
[10]	Pierneef, L, van, Hooij, A, Taal, A, Rumbaut, R, Nobre, M, L., van, Brakel, W and Geluk, A, Detection of anti-M. leprae antibodies in children in leprosy-endemic areas: A systematic review, PLoS Neglected Tropical Diseases, 15, e0009667, 2021.
[11]	Quilter, E, E, Butlin, C, R, Singh, S, Alam, K and Lockwood, D, N, Patients with skin smear positive leprosy in Bangladesh are the main risk factor for leprosy development: 21-year follow-up in the household contact study (COCOA). PLoS Neglected Tropical Diseases, 14, e0008687. 2020.
[12]	Sales-Marques, C, Cardoso, C, C, Alvarado-Arnez, L, E, Illaramendi, X, Sales, A, M, Hacker, M, A, Genetic polymorphisms of the IL6 and NOD2 genes are risk factors for inflammatory reactions in leprosy. PLoS Neglected Tropical Diseases, 11, e0005754.2017.
[13]	Dwivedi, V, P, Banerjee, A, Das, I, Saha, A, Dutta, M and Bhardwaj, B, Diet and nutrition: An important risk factor in leprosy. Microbiolog Pathogen 137, 103714- 103725. 2019.
[14]	Tió-Coma, M, Wijnands, T, Pierneef, L., Schilling, A, K, Alam, K, Roy, J, C and Geluk, A, Detection of Mycobacterium leprae DNA in soil: multiple needles in the haystack. Scientific Reports, 9, 1-7. 2019.
[15]	Vera-Cabrera, L, Ramos-Cavazos, C, J, Youssef, N, A, Pearce, C, M, Molina-Torres C, A, Avalos-Ramirez, R and Avanzi C, Mycobacterium leprae Infection in a Wild Nine-Banded Armadillo, Nuevo León, Mexico, Emerging Infectious Diseases, 28, 747- 749. 2022.
[16]	Coulibaly, N,D, Dehe B, R, Kakou-N’gazoa S, Kouakou H, Amon, A, C, Sylla, A, Bidié P, B, Bamba V, and Dosso, M, Drugs susceptibility testing in leprosy patients from Côte d'Ivoire reveals multidrugs resistance combination cases to dapsone, rifampicin and ofloxacin, American Journal of Microbiological Research, 8, 160-163. 2020.
[17]	Dehe, B, R, Coulibaly, N, D, G, Kouakou, H, Amon, A, C, Kakou-Ngasoa, S, E, Bamba, V, and Dosso, M, Comparative assessments of polymerase chain reaction (PCR) assay of repetitive sequence (RLEP) and proline rich antigen (PRA) gene targets for detection of Mycobacterium leprae DNA from paucibacillary (PB) and multibacillary (MB) patients in Côte d'Ivoire, GSC Biological and Pharmaceutical Sciences, 11, 085-092. 2020.
[18]	Blevins K, Crane A, Lum C, Furuta K, Fox K, and Stone, A, Evolutionary history of Mycobacterium leprae in the Pacific Islands, Philosophical Transactions of the Royal Society Biological Sciences, 375, 20190582-20190593. 2020.
[19]	Amon, A,C, Coulibaly, N,D, Dehe, B,R, Kouakou, H, Kakou-N.S, Djaman, A, J, Bamba V, and Dosso M, "SNP Typing of Mycobacterium leprae Clinical Strains in Côte d'Ivoire Reveals Genotype 4 Circulating," American Journal of Biomedical Research, 9, 30-35. 2021.
[20]	Monot, M, Honoré, N, Garnier, T, Araoz, R, Coppée, J and Lacroix, C, Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nature Genetic, 41, 1282-1289. 2009.
[21]	Schuenemann, V, J, Avanzi, C, Krause-Kyora, B, Ancient genomes reveal a high diversity of Mycobacterium leprae in medieval Europe, PLoS Pathogen, 14(5):e1006997.2018.
[22]	Pfrengle, S, Neukamm, J, Guellil, M, Keller, M, Molak,, M., Avanzi, C, Kushniarevich. A, Montes, N, Neumann, G, Reiter, E, Tukhbatova, R, Berezina, N, Buzhilova, A, Korobov, D, Hamre, S, Matos, V, Ferreira, M, González-Garrido, L, Wasterlain, S, Lopes C, Santos, A, Antunes-Ferreira, N, Duarte, V, Silva, A, Melo. L, Sarkic, N, Saag, L, Tambets, K, Busso, P, Stewart, T, Avlasovich, A, Charlotte, A, Alison, S, Craig, C, Robb, J, Krause, J, Scheib, C, Inskip. S, and Schuenemann, V, Mycobacterium leprae diversity and population dynamics in medieval Europe from novel ancient genomes, BMC Biology, 19, 220. 2021.
[23]	Holanda, M, Marques, L, Macedo, M., Pontes, M, Sabadia, J, Kerr, L, Almeida, R, and Frota, C, Presence of Mycobacterium leprae genotype 4 in environmental waters in Northeast Brazil, Revista da Sociedade Brasileira de Medicina Tropical, 50 (2), 216-222. 2017.